A new Government Accountability Office report (available
here) concludes that the FDA has not made enough changes in staff or procedures to better monitor drug safety, even though experts recommended several key changes back in 2006. For more on this story go
here and
here.
UPDATE (12/10): another take on the report
here.
No comments:
Post a Comment